A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

Abstract Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although PSMA-targeted radiopharmaceutical therapy (RPT) has enabled significant imaging and prostate-specific antigen (PSA) responses, accumulating c...

Full description

Saved in:
Bibliographic Details
Main Authors: Srikanth Boinapally, Hye-Hyun Ahn, Bei Cheng, Mary Brummet, Hwanhee Nam, Kathleen L. Gabrielson, Sangeeta R. Banerjee, Il Minn, Martin G. Pomper
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
R
Q
Online Access:https://doaj.org/article/66509369cb3640a3b49a1ee996b47027
Tags: Add Tag
No Tags, Be the first to tag this record!